Page 106 - Cap Ltd News Today

ANGLE plc: Angle PLC Announces Exercise of Options and Total Voting Rights SURREY, UK / ACCESSWIRE / April 30, 2021 / ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 203,333 new Ordinary shares of £0.10 each ("New Ordinary Shares") in the Company. The New Ordinary Shares rank pari passu with the existing Ordinary shares in the Company. An application has been made to the London Stock...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

Investegate announcements from Angle PLC, Exercise of options and total voting rights

  1.  Parkmead is an independent, UK and Netherlands focused energy group that is listed on AIM on the London Stock Exchange (symbol: PMG). Parkmead is focused on growth in the oil and gas upstream and renewable energy sectors, targeting transactions at both asset and corporate level. 2.  In January 2018, Parkmead significantly increased its equity in the Greater Perth Area oil hub project from 60.05% to 100%. The Group also announced that it had signed an agreement wit...

  finnCap, which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively for Proactis as financial adviser and no one else in connection with the Acquisition and will not be responsible to anyone other than Proactis for providing the protections afforded to clients of finnCap or for providing advice in relation to the Acquisition or any other matters referred to in this announcement. Neither finnCap nor any of its subsidiaries, affiliates or branches owe...

Christopher Raggett, Simon Hicks, Kate Bannatyne (Corporate Finance) Alice Lane, Sunila De Silva (ECM)   About Elixirr International plc Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base. Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced busin...

Grant of Options Director/PDMR Shareholdings Proactis Holdings PLC (the "Company"), the business spend management solution provider, announces that it has adopted a new Long Term Incentive Plan ("LTIP"), with the objective of attracting, motivating and retaining key staff over the medium term. Grants pursuant to the LTIP have been made today at the same time as the cancellation of certain share options previously issued under the Enterprise Management Scheme, the...

ANGLE plc ("ANGLE" or "the Company") Preliminary Results for the year ended 31 December 2020 FDA SUBSTANTIVE REVIEW PROGRESSING LAUNCH OF CLINICAL LABORATORY SERVICES FIRST LARGE-SCALE CONTRACT WITH

120% revenue and 5 times EBITDA growth delivers first annual profit Argo Blockchain Plc, a global leader in cryptocurrency mining (LSE: ARB), is pleased to announce its audited results for the year ended 31 December 2020. Financial Revenue increased by 120% to £19.0m (2019: £8.6m) Total number of Bitcoins mined rose from 1,330 in 2019 to 2,465 in 2020, an 85% increase in annual production Mining margin 41% (2019: 60%) despite challenging market conditions, including Bitcoin halving in May 202...

      ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, today announces audited preliminary results for the year ended 31 December 2020.     · Full De Novo Submission made in September 2020 for US Food and Drug Administration (FDA) clearance of the Parsortix ® system for capturing and harvesting circulating tumour cells from metastatic breast cancer patients -  FDA Administrative Review complete and Substantive Revi...